课题基金 / 基金详情

Establishment of disease entity for lung cancer in never-smokers

Establishment of disease entity for lung cancer in never-smokers
从不吸烟者肺癌疾病实体的建立
批准号:
21591816
负责人:
YANO Tokujiro
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We investigated the difference of molecular biology between never-smoked non-small cell lung cancer(NSCLC) and smoked NSCLC. As far as we examined, only high incidence of EGFR mutation in never-smoked NSCLC was recognized. On the other hand, the level of AOC(anti-oxidant capacity) was significantly lower in never-smoked NSCLC patients than in ever-smoked ones although there was no significant relationship between serum OS(oxidative stress) level and smoking status. In addition, the oxidative DNA damage rate of never-smoked NSCLC patients was significantly higher than that of patients with benign diseases. In conclusion, the low AOC in never-smoked NSCLC might be attributed to the excessive oxidative DNA damages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biological significance of the maximum standardized uptake values on position emission tomography in non-small cell lung cancer
非小细胞肺癌位置发射断层扫描最大标准化摄取值的生物学意义
DOI: --
发表时间: 2009
期刊: J Surg Oncol
影响因子: 2.5
作者: [Takenaka T, Yano T, Ito K, Morodomi Y, Miura N, Kawano D, Shoji F, Abe K, Honda H, Maehara Y]
通讯作者: Maehara Y
病理病期IA期非小細胞肺癌における腫瘍内血管浸潤の臨床的意義-新T因子分類と腫瘍内血管浸潤による術後再発症例の予測
病理IA期非小细胞肺癌瘤内血管侵犯的临床意义——基于瘤内血管侵犯的新T因子分类及术后复发预测
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [庄司文裕、矢野篤次郎, 他]
通讯作者:
ガイドライン治療・臨床試験に該当しない症例に対する治療:肺癌術後再発例に対する治療戦略
不适合指南治疗/临床试验病例的治疗:肺癌术后复发的治疗策略
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [矢野篤次郎, 庄司文裕, 波呂祥, 諸富洋介, 伊藤謙作, 吉田月久, 前原喜彦, 矢野篤次郎]
通讯作者: 矢野篤次郎
DOI: 10.1016/j.mrgentox.2009.05.008
发表时间: 2009-06-01
期刊: MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
影响因子: 1.9
作者: [Ohba, Taro, Kometani, Takurou, Maehara, Yoshihiko]
通讯作者: Maehara, Yoshihiko
45
    海外基金